Visionary Healthcare Investors
BioStar Capital is making a difference in patients' lives with uncompromising fund performance.
Business Acumen Meets
Clinical Expertise
The BioStar team represents a unique collaboration between experienced investment professionals and clinicians with global reputations as medical thought leaders.
Innovations with an Impact
For over 17 years, BioStar Capital has been at the forefront of transformational medical technology through partnerships with innovative companies.
Portfolio News
January 5, 2022
Senseonics expects FDA approval for next-gen 180-day CGM in ‘coming weeks’
BioStar News
May 25, 2021
Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence
January 15, 2021
DeviceTalks Weekly features Mark Toland, BioStar Entrepreneur-in-Residence: Digging into the Digital Medtech & Surgical Worlds